Dr. Navdeep Singh is an experienced fertility specialist with a strong background in reproductive medicine, obstetrics, and gynaecology. Before joining Alpha IVF & Women’s Specialists, he served as the Consultant O&G and Fertility Specialist, and the Medical Director of TMC Fertility & Women’s Specialist Centre where he served for 14 years. He oversaw TMC Fertility branches in Puchong, Penang, Ipoh and Johor Bharu. He is also the immediate Past President of the Malaysian Society for Assisted Reproductive Technology (MSART), contributing significantly to the advancement of fertility care in Malaysia. Dr. Navdeep is also involved regionally. He is the Malaysian representative at Asia Pacific Initiative on Reproduction (ASPIRE) and a committee member in the special interest group for education.
Dr. Navdeep obtained his Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) from Jawaharlal Nehru Medical College, India, in 1998, before completing his Master of Obstetrics & Gynaecology (M. Med. O&G) at the University of Malaya in 2009. He further honed his expertise with international recognition, earning his Membership with the Royal College of Obstetricians & Gynaecologists (M.R.C.O.G., UK) in 2010 and later his Fellowship (F.R.C.O.G., UK) in 2023.
His professional training includes:
- Fellowship & Diploma in Minimal Access Surgery (F.MAS & D.MAS) – World Laparoscopy Hospital, India (2011)
- Assisted Reproductive Technique Course for Clinicians – National University Hospital, Singapore (2012)
- Master Certificate in Reproductive Medicine – Homerton University Hospital, UK (2019)
Dr. Navdeep has also been actively involved in research and has contributed to multiple studies in reproductive medicine, including:
- The dilemma of antenatal corticosteroid regimens, which is better?
- Hospital Tengku Ampuan Rahimah, Klang (2007)
- The Impact of lymphovascular space invasion on the survival and recurrence in patients with endometrial carcinoma
- University Malaya Medical Centre (2007)
- Evaluation of Assisted Reproductive Technology (ART) treatment outcomes based on stimulation dosages and Anti-Mullerian Hormone (AMH) levels
- TMC Fertility & Women’s Specialists Centre, Puchong (2022)
His work has been presented at prestigious conferences, including the Obstetrical and Gynaecological Society of Malaysia Conference, where he won third prize for his research on antenatal corticosteroid regimens.
1. Current research:
Involved as the Coordinating principal investigator. Collaboration between Ferring, MSART and clinicians from Malaysian fertility centres.
Title: Assessment of the use of REKOVELLE Individualized and Equivalence dosing regimens in Women Undergoing IVF or ICSI Procedures in Routine Clinical Practice.
2. Submitted for publication.
As first author and lead investigator. Involving all TMC Fertility and women’s specialist centres in Malaysia.
Title: The clinical utility of endometrial receptivity testing according to infertility diagnosis.
Dr. Navdeep is a member of various professional bodies, including:
- Malaysian Society for Assisted Reproductive Technology (MSART)
- Academy of Medicine Malaysia
- Obstetrical and Gynaecological Society of Malaysia (OGSM)
- Malaysian Medical Association (MMA)
- American Society for Reproductive Medicine (ASRM)
- European Society of Human Reproduction & Embryology (ESHRE)
With his extensive clinical experience, research contributions, and commitment to patient care, Dr. Navdeep brings valuable expertise to Alpha IVF & Women’s Specialists, further strengthening its position as a leader in fertility treatment.
Dr Navdeep Singh Pannu
MBBS (India), M.MED. O&G (Malaya),
FRCOG (London), A.M. (Malaysia)
Cert. Assisted Reproductive Technologies (Singapore)
Fellowship & Diploma in Minimal Access Surgery (India)
